Comprehensive transcriptomic profiling reveals molecular characteristics and biomarkers associated with risk stratification in papillary thyroid carcinoma
The Journal of Pathology: Clinical Research · 2025
DOI: 10.1002/2056-4538.70022 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Pathology: Clinical Research, 2025. Verfasst von Congcong Yan und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering, Wenzhou Medical University, Wenzhou, PR China. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Thyroid Cancer, Papillary, Gene Expression Profiling, Biomarkers, Tumor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Major Science and Technology Innovation Program of Wenzhou.
Abstract (Originalsprache)
Papillary thyroid carcinoma (PTC) is one of the most common endocrine malignancies, with varying levels of risk and clinical behavior. A better understanding of the molecular characteristics could improve molecular diagnosis and risk assessment. In this study, we performed whole transcriptomic sequencing on 113 PTC cases, including 70 high‐risk and 43 low‐risk Chinese patients. Comparative transcriptional profiling analysis revealed two functionally distinct patterns of gene dysregulation between the risk subtypes. Low‐risk PTCs showed significant upregulation of immune‐related genes and increased immune cell infiltration, whereas high‐risk PTCs presented extensive alterations in gene expression and activation of oncogenic signaling pathways. Additionally, we developed a 31‐gene transcriptomic signature (PTCrisk) for differentiating high‐risk from low‐risk PTCs, which was validated across both in‐house and external multicenter cohorts. PTCrisk scores were positively correlated with key clinicopathological features, including tumor size, lymph node metastasis, TNM stage, and BRAF mutation status. Overall, our study provides further molecular insights into PTC risk stratification and may contribute to the development of personalized therapeutic strategies for PTC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biomedical Engineering, Wenzhou Medical University, Wenzhou, PR China.
- Department of Breast Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, PR China.
- Department of Surgical Oncology, Wenzhou Central Hospital and Sixth People's Hospital of Wenzhou, Wenzhou, PR China.
ORCID-Profile: Meng Zhou
Förderung
- Major Science and Technology Innovation Program of Wenzhou
Zitieren
APA
Yan, C., Zheng, C., Luo, J., Wu, X., Meng, X., Lv, C., Shen, S., Zhou, M., & Wang, O. (2025). Comprehensive transcriptomic profiling reveals molecular characteristics and biomarkers associated with risk stratification in papillary thyroid carcinoma. The Journal of Pathology: Clinical Research. https://doi.org/10.1002/2056-4538.70022
Vancouver
Yan C, Zheng C, Luo J, Wu X, Meng X, Lv C, et al. Comprehensive transcriptomic profiling reveals molecular characteristics and biomarkers associated with risk stratification in papillary thyroid carcinoma. The Journal of Pathology: Clinical Research. 2025. doi:10.1002/2056-4538.70022
BibTeX
@article{Yan2025,
author = {Yan, Congcong and Zheng, Chen and Luo, Jiaxing and Wu, Xue and Meng, Xinyu and Lv, Chaoyue and Shen, Shurong and Zhou, Meng and Wang, Ouchen},
title = {Comprehensive transcriptomic profiling reveals molecular characteristics and biomarkers associated with risk stratification in papillary thyroid carcinoma},
journal = {The Journal of Pathology: Clinical Research},
year = {2025},
doi = {10.1002/2056-4538.70022}
}
EUVIMED